201 related articles for article (PubMed ID: 21324901)
21. A single chain variable fragment antibody (Tn 64) cognate to fibronectin type III repeats promotes corneal wound healing by inhibiting fibrosis.
Shukla A; Suresh V; Gupta PC; Sharma M; Saikia UN; Ram J; Luthra-Guptasarma M
Int Immunopharmacol; 2024 May; 133():112029. PubMed ID: 38640715
[TBL] [Abstract][Full Text] [Related]
22. Involvement of chondroitin sulfates on brain-derived tenascin-R in carbohydrate-dependent interactions with fibronectin and tenascin-C.
Probstmeier R; Braunewell K; Pesheva P
Brain Res; 2000 Apr; 863(1-2):42-51. PubMed ID: 10773191
[TBL] [Abstract][Full Text] [Related]
23. Kinetic partitioning mechanism governs the folding of the third FnIII domain of tenascin-C: evidence at the single-molecule level.
Peng Q; Fang J; Wang M; Li H
J Mol Biol; 2011 Sep; 412(4):698-709. PubMed ID: 21839747
[TBL] [Abstract][Full Text] [Related]
24. Cleavage of extracellular matrix in periodontitis: gingipains differentially affect cell adhesion activities of fibronectin and tenascin-C.
Ruggiero S; Cosgarea R; Potempa J; Potempa B; Eick S; Chiquet M
Biochim Biophys Acta; 2013 Apr; 1832(4):517-26. PubMed ID: 23313574
[TBL] [Abstract][Full Text] [Related]
25. Utilization of a soluble integrin-alkaline phosphatase chimera to characterize integrin alpha 8 beta 1 receptor interactions with tenascin: murine alpha 8 beta 1 binds to the RGD site in tenascin-C fragments, but not to native tenascin-C.
Denda S; Müller U; Crossin KL; Erickson HP; Reichardt LF
Biochemistry; 1998 Apr; 37(16):5464-74. PubMed ID: 9548928
[TBL] [Abstract][Full Text] [Related]
26. Multiple Cryptic Binding Sites are Necessary for Robust Fibronectin Assembly: An In Silico Study.
Lemmon CA; Weinberg SH
Sci Rep; 2017 Dec; 7(1):18061. PubMed ID: 29273802
[TBL] [Abstract][Full Text] [Related]
27. Mechanical design of the third FnIII domain of tenascin-C.
Peng Q; Zhuang S; Wang M; Cao Y; Khor Y; Li H
J Mol Biol; 2009 Mar; 386(5):1327-42. PubMed ID: 19452631
[TBL] [Abstract][Full Text] [Related]
28. Assembly of fibronectin extracellular matrix.
Singh P; Carraher C; Schwarzbauer JE
Annu Rev Cell Dev Biol; 2010; 26():397-419. PubMed ID: 20690820
[TBL] [Abstract][Full Text] [Related]
29. Solution structure of a type 2 module from fibronectin: implications for the structure and function of the gelatin-binding domain.
Pickford AR; Potts JR; Bright JR; Phan I; Campbell ID
Structure; 1997 Mar; 5(3):359-70. PubMed ID: 9083105
[TBL] [Abstract][Full Text] [Related]
30. The glia-derived extracellular matrix glycoprotein tenascin-C promotes embryonic and postnatal retina axon outgrowth via the alternatively spliced fibronectin type III domain TNfnD.
Siddiqui S; Horvat-Bröcker A; Faissner A
Neuron Glia Biol; 2008 Nov; 4(4):271-83. PubMed ID: 19508743
[TBL] [Abstract][Full Text] [Related]
31. Role of material-driven fibronectin fibrillogenesis in cell differentiation.
Salmerón-Sánchez M; Rico P; Moratal D; Lee TT; Schwarzbauer JE; García AJ
Biomaterials; 2011 Mar; 32(8):2099-105. PubMed ID: 21185593
[TBL] [Abstract][Full Text] [Related]
32. Adaptation of the group A Streptococcus adhesin Scl1 to bind fibronectin type III repeats within wound-associated extracellular matrix: implications for cancer therapy.
McNitt DH; Choi SJ; Allen JL; Hames RA; Weed SA; Van De Water L; Berisio R; Lukomski S
Mol Microbiol; 2019 Sep; 112(3):800-819. PubMed ID: 31145503
[TBL] [Abstract][Full Text] [Related]
33. Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen.
Steffensen B; Wallon UM; Overall CM
J Biol Chem; 1995 May; 270(19):11555-66. PubMed ID: 7744795
[TBL] [Abstract][Full Text] [Related]
34. Probing the conformation of the fibronectin III1-2 domain by fluorescence resonance energy transfer.
Karuri NW; Lin Z; Rye HS; Schwarzbauer JE
J Biol Chem; 2009 Feb; 284(6):3445-52. PubMed ID: 19064996
[TBL] [Abstract][Full Text] [Related]
35. Staphylococcal superantigen-like protein 8 (SSL8) binds to tenascin C and inhibits tenascin C-fibronectin interaction and cell motility of keratinocytes.
Itoh S; Yamaoka N; Kamoshida G; Takii T; Tsuji T; Hayashi H; Onozaki K
Biochem Biophys Res Commun; 2013 Mar; 433(1):127-32. PubMed ID: 23485472
[TBL] [Abstract][Full Text] [Related]
36. Stabilization of the third fibronectin type III domain of human tenascin-C through minimal mutation and rational design.
Gilbreth RN; Chacko BM; Grinberg L; Swers JS; Baca M
Protein Eng Des Sel; 2014 Oct; 27(10):411-8. PubMed ID: 24996411
[TBL] [Abstract][Full Text] [Related]
37. Engineering fibronectin-templated multi-component fibrillar extracellular matrices to modulate tissue-specific cell response.
Ahn S; Jain A; Kasuba KC; Seimiya M; Okamoto R; Treutlein B; Müller DJ
Biomaterials; 2024 Jul; 308():122560. PubMed ID: 38603826
[TBL] [Abstract][Full Text] [Related]
38. Glial tumor cell adhesion is mediated by binding of the FNIII domain of receptor protein tyrosine phosphatase beta (RPTPbeta) to tenascin C.
Adamsky K; Schilling J; Garwood J; Faissner A; Peles E
Oncogene; 2001 Feb; 20(5):609-18. PubMed ID: 11313993
[TBL] [Abstract][Full Text] [Related]
39. Fibronectin: Molecular Structure, Fibrillar Structure and Mechanochemical Signaling.
Dalton CJ; Lemmon CA
Cells; 2021 Sep; 10(9):. PubMed ID: 34572092
[TBL] [Abstract][Full Text] [Related]
40. Interdomain association in fibronectin: insight into cryptic sites and fibrillogenesis.
Vakonakis I; Staunton D; Rooney LM; Campbell ID
EMBO J; 2007 May; 26(10):2575-83. PubMed ID: 17464288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
